Precocious Puberty Clinical Trials

Find Precocious Puberty Clinical Trials Near You

Idiopathic Central Precocious Puberty and Associated Neurodevelopmental Syndromes and Pathologies: Evaluation of Frequency and Comparison of Diagnostic and Developmental Characteristics

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Observational, retrosopective, single-centre, non-profit study focused on the frequency of Central Precocious Puberty idiopathic, or associated to Neurodevelopmental Syndromes and Pathologies, and comparison of diagnostic and developmental characteristics of patients.

Eligibility
Participation Requirements
Sex: All
Maximum Age: 18
Healthy Volunteers: f
View:

• Patients diagnosed with Central Precocious Puberty presenting an indication to undertake treatment with GnRH analogue: Appearance of secondary sexual characteristics (thelarche or gonadarche) before the age of 8 for females and 9 for males; Acceleration of the rate of statural growth and advancement of bone age one year older than the chronological age; LH peak \> 5 IU/L on GnRH test and a longitudinal uterine diameter \> 36 mm in females, with or without the appearance of endometrial rhyme;

• Age at onset of entral Precocious Puberty between 2 and 8 years (females) or between 2 and 9 years (males);

• Age at enrollment \< 18 years;

• Follow-up of at least 12 months;

• Obtaining informed consent from parents/legal guardian of peduatric patients.

Locations
Other Locations
Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna
RECRUITING
Bologna
Contact Information
Primary
Federico Baronio, MD
federico.baronio@aosp.bo.it
00390512144816
Time Frame
Start Date: 2024-03-13
Estimated Completion Date: 2027-05-13
Participants
Target number of participants: 300
Related Therapeutic Areas
Sponsors
Leads: IRCCS Azienda Ospedaliero-Universitaria di Bologna

This content was sourced from clinicaltrials.gov